1. Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents

   • Marco Zimarino
   • Giulia Renda
   • Raffaele De Caterina

   Current Opinion 19 September 2012 Pages: 725 - 732

   

2. Improving Outcomes in Advanced Malignant Melanoma

   • Sarah Danson
   • Paul Lorigan

   Leading Article 19 September 2012 Pages: 733 - 743

   

3. Anaesthetic Agents for Advanced Regional Anaesthesia

   • Chester C. Buckenmaier III
   • Lisa L. Bleckner

   Therapy in Practice 19 September 2012 Pages: 745 - 759

   

4. Bronchiolitis Obliterans Syndrome

   • Andrew I. R. Scott
   • Linda D. Sharples
   • Susan Stewart

   Review Article 19 September 2012 Pages: 761 - 771

   

5. Sexual Dysfunction in Male Patients with Hypertension

   • Rainer Düsing

   Review Article 19 September 2012 Pages: 773 - 786

6. Optimising the Use of β-Adrenoceptor Antagonists in Coronary Artery Disease

   • Kristin E. Ellison
   • Gaurang Gandhi

   Review Article 19 September 2012 Pages: 787 - 797

   

7. Mycophenolate Sodium Delayed Release

   • Monique P. Curran
   • Gillian M. Keating

   Adis Drug Profile 19 September 2012 Pages: 799 - 805

   

8. Mycophenolate Sodium Delayed Release

   • Maurizio Salvadori

   Adis Drug Profile 19 September 2012 Pages: 806 - 806

9. Mycophenolate Sodium Delayed Release

   • Matthias Behrend

   Adis Drug Profile 19 September 2012 Pages: 806 - 807

10. Peginterferon-α-2a (40kD)

    • Gayle W. Robins
    • Lesley J. Scott
    • Gillian M. Keating

    Adis Drug Evaluation 19 September 2012 Pages: 809 - 825

    

11. Tacrolimus Ointment

    • Dene Simpson
    • Stuart Noble

    Adis Drug Evaluation 19 September 2012 Pages: 827 - 859

    

12. Valganciclovir

    • Risto S. Cvetkovic
    • Keri Wellington

    Adis Drug Evaluation 19 September 2012 Pages: 859 - 878